EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
NORBERTO OCTAVIO
CORRAL BLANCO
Catedrático de Universidad
Publications dans lesquelles il/elle collabore avec NORBERTO OCTAVIO CORRAL BLANCO (10)
2010
-
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: Study based on experience at the Hospital Universitario Central de Asturias
Clinical and Translational Oncology, Vol. 12, Núm. 8, pp. 562-567
2007
-
Cisplatin plus gemcitabine with or without vinorelbine as induction chemotherapy prior to radical locoregional treatment for patients with stage III non-small-cell lung cancer (NSCLC): Results of a prospective randomized study
Lung Cancer, Vol. 55, Núm. 2, pp. 173-180
-
Estudio retrospectivo en pacientes con diagnóstico de carcinoma de pulmón no microcítico estadio avanzado tratados con la combinación gemcitabina y vinorelbina: Valoración de la eficacia terapéutica y factores pronósticos
Oncologia, Vol. 30, Núm. 2, pp. 32-43
2006
-
Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study
Investigational New Drugs, Vol. 24, Núm. 3, pp. 241-248
2003
-
Combination of docetaxel, epirubicin and vinorelbine administered every 2 weeks as first-line therapy in patients with metastatic breast cancer: A dose-finding study
Breast Cancer Research and Treatment, Vol. 80, Núm. 3, pp. 257-265
-
Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
Annals of Oncology, Vol. 14, Núm. 11, pp. 1640-1647
2002
-
Phase I/II study of gemcitabine and vinorelbine plus cisplatin in non-small cell lung cancer
Investigational New Drugs, Vol. 20, Núm. 3, pp. 317-326
-
Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer
Investigational New Drugs, Vol. 20, Núm. 1, pp. 73-82
1999
-
Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer
Breast Cancer Research and Treatment, Vol. 58, Núm. 2, pp. 141-150